Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry?

Author: Hemphill Thomas  

Publisher: Springer Publishing Company

ISSN: 0167-4544

Source: Journal of Business Ethics, Vol.94, Iss.2, 2010-06, pp. : 225-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract